
Rupen Shah
@rupenshahmd
Surgical Oncologist @HenryFordHealth, Program Director @HFHSurgery. Alum of @HFHSurgery & KMC Surgery Residencies and @RoswellPark Fellowship. Views are my own.
ID: 17693095
27-11-2008 23:34:34
3,3K Tweet
1,1K Takipçi
1,1K Takip Edilen

Presenting PICOLLA study joining COLOPEC trial and HIPECT4 trial. HIPEC prevent recurrences in right-t4 advanced colon cancer Peritoneal Surface Oncology Group International European Society of Surgical Oncology (ESSO) ISSPP SEOQ | Los cirujanos del cáncer #operarelcancer Kiran Turaga Delia Cortés Guiral Martin Hübner IMIBIC Hospital Universitario Reina Sofía



Led by @LahayeMax on behalf of the Peritoneal Surface Oncology Group International and ESGAR, the guidelines on imaging for peritoneal metastases of colorectal and ovarian origin are now available link.springer.com/article/10.100… 🔓 Open access with Ignace de Hingh #PascalRousset Artem Stepanyan #StephanieNougaret




My🔝10📝of2⃣0⃣2⃣4⃣(cont'd) NETTER 2 in The Lancet RCT - ☢️PRRT vs long-acting SSA in G2/3 advanced GEP-NETs ⬆️PFS by >12 months median HR 0.28 (0.18–0.42) Across all sub-groups 💥 New standard of care for 2025? 🦓 thelancet.com/journals/lance…







GEP‐NETs are the 2nd most prevalent neoplasm of gastrointestinal origin after #ColorectalCancer. AJCC outlines their version 9 updates, including advocating against the use of serum chromogranin A for the diagnosis & monitoring of GEP‐NETs. Read at: acsjournals.onlinelibrary.wiley.com/doi/full/10.33…


Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma SURGERY Journal surgjournal.com/article/S0039-…

Resect or ablate small CRLM?🧐 💥COLLISION trial - stopped early 👥300 pts with <=10 mets <=3cm Ablation🆚Resection ⬇️morbidity w ablation - 19 vs 46% ✅OS non-inferior No diff local control Where do we go next - new SOC?🤯 Join #SSO2025 to hear Åsmund A. Fretland on this topic!






